Results and Publications

The soluble receptor for advanced glycation end products (sRAGE) can prospectively identify patients at greatest risk for preterm birth

Bastek JA, Brown AG, Foreman MN, McShea MA, Anglim LM, Adamczak JE, Elovitz MA.: The soluble receptor for advanced glycation end products (sRAGE) can prospectively identify patients at greatest risk for preterm birth. J Matern Fetal Neonatal Med February 2012.

U.S. National Library of Medicine abstract

Clinical Trials Now Recruiting!

Active Clinical Trials

Fertility and the BRCA gene

Studies on the Epigenetic Regulation of Human Pregnancy in  Fertile and Infertile Couples and Placental Parameters Sub-Study

Infertility

Paid research study seeking healthy women who are not at risk for pregnancy

Infertility study

Non-hormonal intrauterine device